D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2 (disulfide bridge: 2-6) acetateProduct ingredient for TT-232

Show full entry for TT-232
Name
D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2 (disulfide bridge: 2-6) acetate
Drug Entry
TT-232

Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).

See full entry for TT-232
Accession Number
DBSALT003321
Structure
Synonyms
Not Available
UNII
QRJ8C05E9C
CAS Number
Not Available
Not Available
Predicted Properties
Not Available